Caiwen Du
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Immunology
- Topics
- HER2/EGFR in Cancer Research (9 papers)Retinoids in leukemia and cellular processes (8 papers)Cancer Treatment and Pharmacology (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Caiwen Du
39 papers receiving 789 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 473
- Oncology 416
- Cancer Research 250
- Pulmonary and Respiratory Medicine 168
- Immunology 92
Countries citing papers authored by Caiwen Du
This map shows the geographic impact of Caiwen Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caiwen Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caiwen Du more than expected).
Fields of papers citing papers by Caiwen Du
This network shows the impact of papers produced by Caiwen Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caiwen Du. The network helps show where Caiwen Du may publish in the future.
Co-authorship network of co-authors of Caiwen Du
This figure shows the co-authorship network connecting the top 25 collaborators of Caiwen Du. A scholar is included among the top collaborators of Caiwen Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caiwen Du. Caiwen Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 8 | |
| 10 | Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. | 181 |
| 11 | 35 | |
| 12 | 50 | |
| 13 | 22 | |
| 14 | 18 | |
| 15 | 1 | |
| 16 | Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment | 9 |
| 17 | 63 | |
| 18 | 14 | |
| 19 | Effect of arsenic trioxide on Epstein-Barr virus latent membrane protein 1-mediated E-cadherin silencing in nasopharyngeal carcinoma | 3 |
| 20 | 1 |
About Caiwen Du
Caiwen Du is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 45 papers that have together received 803 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Cancer Research (250 citations), Oncology (416 citations) and Molecular Biology (473 citations). Caiwen Du has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guo‐Jun Zhang, Wen-Jia Chen, Xiaoli Li, Jiaxin Shen, Jing Liu, Hua-Tao Wu, Xiaolong Wei, Jing‐Wen Bai, Ping Yang and Xiaowei Dou. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.